Biotech

All Articles

8 months after a $213M fundraise, genetics publisher Tome creates cuts

.After rearing $213 million in 2023-- one of the year's biggest private biotech shots-- Tome Bioscie...

BioMarin builds director staff with biotech veterinarians-- Chutes &amp Ladders

.Invite to this week's Chutes &amp Ladders, our roundup of notable leadership hirings, firings as we...

Biopharma Q2 VC attacked highest degree because '22, while M&ampA slowed down

.Equity capital backing into biopharma rose to $9.2 billion all over 215 sell the 2nd quarter of thi...

Bicara, Zenas look for IPOs to press late-phase possessions toward market

.Bicara Rehabs and also Zenas Biopharma have actually provided fresh inspiration to the IPO market w...

Genentech to finalize cancer cells immunology research study department

.Genentech will definitely close its cancer immunology research division, and unit mind and also ren...

Kezar goes down solid cyst however to prove its worth in period 1 test

.Kezar Lifestyle Sciences is actually falling its own unpromising period 1 strong tumor drug as the ...

Acelyrin loses izokibep, lets go 3rd of team

.Even with izokibep preserving its newly found winning streak in the medical clinic, Acelyrin is act...

Rivus' stage 2 obesity-related cardiac arrest test strikes endpoint

.Rivus Pharmaceuticals has plumped up the prospects of its fat-busting, muscle-sparing medicine appl...

Ovid stops preclinical work, IV system after soticlestat fail

.Ovid Rehab presently revealed final month that it was actually trimming back its head count as the ...

Eli Lilly opens up $700M nucleic acid R&ampD facility in Boston Seaport

.Eli Lilly has actually opened a $700 thousand R&ampD center in the Boston ma Seaport, enhancing its...